Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
IntermesticTSE:262A -1.68%16 EBITDA Margin % is 0.00% as of Jun. 2026. GuruFocus rates TSE:262A with a GF Score™ of 16/100. The stock has 4 warning signs investors should review. Among 814 Medical Devices & Instruments companies, Intermestic ranks better than 58.85% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Intermestic's EBITDA for the
three
months ended in Jun. 2026 was 円0 Mil. Intermestic's Revenue for the
three
months ended in Jun. 2026 was 円0 Mil. Therefore, Intermestic's EBITDA margin for the quarter that ended in Jun. 2026 was 0.00%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Intermestic EBITDA Margin % Related Terms
Intermestic EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Intermestic's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:262A vs ISRG, BDX, MDLN: EBITDA Margin % Comparison
For the Medical Instruments & Supplies subindustry, Intermestic's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Intermestic EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Intermestic's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Intermestic's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Intermestic (TSE:262A) has a EBITDA Margin % of 0.00% as of Jun. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Intermestic and its competitors. Over the past decade, Intermestic's EBITDA Margin % has ranged from 8.69 to 14.17. According to the industry distribution chart, Intermestic ranks #335 out of 814 companies in the Medical Devices & Instruments industry, placing it in the top 41.2%.
Is Intermestic's EBITDA Margin % too high?
Intermestic's current EBITDA Margin % is 0.00%. Over the past 10 years, this metric has ranged from a low of 8.69 to a high of 14.17. Based on the distribution chart, Intermestic ranks #335 out of 814 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Intermestic has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Intermestic's EBITDA Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Intermestic ranks #335 out of 814 companies for EBITDA Margin %. This puts Intermestic in the upper half of its industry. The industry median EBITDA Margin % is 7.96. Historically, Intermestic's own EBITDA Margin % has ranged from 8.69 to 14.17 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.96, based on 814 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Intermestic and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Intermestic's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Intermestic stock overvalued right now?
Intermestic (TSE:262A) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. Intermestic's overall GF Score™ is 16/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Intermestic (TSE:262A), the current EBITDA Margin % is 0.00% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:262A has been successfully added to your 
